On 2 November 2022, the Intellectual Property Tribunal of the Supreme People’s Court published its decision on the trade secret infringement case of Wuwei Bosheng Seed Industry Limited Company (Appellant) v. Hebei Huasui Seed Industry Limited Company. This case raised the untested question of whether parent material used in breeding can be protected as a trade secret in China.
On 21 November 2022, the People’s Republic of China’s Ministry of Agriculture and Rural Affairs issued the revised draft of the Regulations of the People’s Republic of China on the Protection of New Plant Varieties, which is open for public comments until 22 December 2022. The revisions aim to align the Regulations with the revised PRC Seed Law, which has been effective since 1 March 2022, and which provides more detailed and wider protection for plant variety rights in China.
The Australian Government recently introduced new manufacturing, labelling and packaging requirements for medicinal cannabis products manufactured or supplied in Australia, under amendments to the Therapeutic Goods (Standard for Medicinal Cannabis) (TGO 93) Amendment Order 2022 (Amendment Order), effective as of 28 March 2022.